{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:07:18Z","timestamp":1779394038756,"version":"3.53.1"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/ncb3015","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T06:57:52Z","timestamp":1406876272000},"page":"717-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":811,"title":["The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis"],"prefix":"10.1038","volume":"16","author":[{"given":"Sandra S.","family":"McAllister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"BFncb3015_CR1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","volume":"9","author":"JA Joyce","year":"2009","unstructured":"Joyce, J. A. & Pollard, J. W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239\u2013252 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR2","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.yexcr.2010.02.045","volume":"316","author":"K Pietras","year":"2010","unstructured":"Pietras, K. & Ostman, A. Hallmarks of cancer: interactions with the tumor stroma. Exp. Cell Res. 316, 1324\u20131331 (2010).","journal-title":"Exp. Cell Res."},{"key":"BFncb3015_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","volume":"6","author":"M Allinen","year":"2004","unstructured":"Allinen, M. et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17\u201332 (2004).","journal-title":"Cancer Cell"},{"key":"BFncb3015_CR4","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1371\/journal.pbio.0020007","volume":"2","author":"HY Chang","year":"2004","unstructured":"Chang, H. Y. et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2, E7 (2004).","journal-title":"PLoS Biol."},{"key":"BFncb3015_CR5","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/bcr1608","volume":"8","author":"G Finak","year":"2006","unstructured":"Finak, G. et al. Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res. 8, R58 (2006).","journal-title":"Breast Cancer Res."},{"key":"BFncb3015_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10549-008-9982-8","volume":"114","author":"T Casey","year":"2009","unstructured":"Casey, T. et al. Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Res. Treat. 114, 47\u201362 (2009).","journal-title":"Breast Cancer Res. Treat."},{"key":"BFncb3015_CR7","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/bcr2222","volume":"11","author":"XJ Ma","year":"2009","unstructured":"Ma, X. J., Dahiya, S., Richardson, E., Erlander, M. & Sgroi, D. C. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 11, R7 (2009).","journal-title":"Breast Cancer Res."},{"key":"BFncb3015_CR8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0306-9877(78)90002-6","volume":"4","author":"G Zajicek","year":"1978","unstructured":"Zajicek, G. Cancer as a systemic disease. Med. Hypotheses 4, 193\u2013207 (1978).","journal-title":"Med. Hypotheses"},{"key":"BFncb3015_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/joim.12084","volume":"274","author":"AJ Redig","year":"2013","unstructured":"Redig, A. J. & McAllister, S. S. Breast cancer as a systemic disease: a view of metastasis. J. Intern. Med. 274, 113\u2013126 (2013).","journal-title":"J. Intern. Med."},{"key":"BFncb3015_CR10","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650\u20131659 (1986).","journal-title":"N. Engl. J. Med."},{"key":"BFncb3015_CR11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrc3217","volume":"12","author":"EN Arwert","year":"2012","unstructured":"Arwert, E. N., Hoste, E. & Watt, F. M. Epithelial stem cells, wound healing and cancer. Nat. Rev. Cancer 12, 170\u2013180 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860\u2013867 (2002).","journal-title":"Nature"},{"key":"BFncb3015_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE De Visser","year":"2006","unstructured":"De Visser, K. E., Eichten, A. & Coussens, L. M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6, 24\u201337 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436\u2013444 (2008).","journal-title":"Nature"},{"key":"BFncb3015_CR15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883\u2013899 (2010).","journal-title":"Cell"},{"key":"BFncb3015_CR16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev-immunol-020711-075008","volume":"30","author":"G Trinchieri","year":"2012","unstructured":"Trinchieri, G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 30, 677\u2013706 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"BFncb3015_CR17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrc1094","volume":"3","author":"R Kalluri","year":"2003","unstructured":"Kalluri, R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3, 422\u2013433 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbadis.2012.12.001","volume":"1832","author":"M Lech","year":"2013","unstructured":"Lech, M. & Anders, H. J. Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. Biochim. Biophys. Acta 1832, 989\u2013997 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFncb3015_CR19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tig.2008.10.012","volume":"25","author":"K Polyak","year":"2009","unstructured":"Polyak, K., Haviv, I. & Campbell, I. G. Co-evolution of tumor cells and their microenvironment. Trends Genet. 25, 30\u201338 (2009).","journal-title":"Trends Genet."},{"key":"BFncb3015_CR20","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbadis.2012.10.013","volume":"1832","author":"T Marsh","year":"2012","unstructured":"Marsh, T., Pietras, K. & McAllister, S. S. Fibroblasts as architects of cancer pathogenesis. Biochim. Biophys. Acta 1832, 1070\u20131078 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFncb3015_CR21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/35094059","volume":"1","author":"MJ Bissell","year":"2001","unstructured":"Bissell, M. J. & Radisky, D. Putting tumours in context. Nat. Rev. Cancer 1, 46\u201354 (2001).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrc2507","volume":"8","author":"B Seruga","year":"2008","unstructured":"Seruga, B., Zhang, H., Bernstein, L. J. & Tannock, I. F. Cytokines and their relationship to the symptoms and outcome of cancer. Nat. Rev. Cancer 8, 887\u2013899 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.molmed.2009.06.006","volume":"15","author":"D Gao","year":"2009","unstructured":"Gao, D. & Mittal, V. The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol. Med. 15, 333\u2013343 (2009).","journal-title":"Trends Mol. Med."},{"key":"BFncb3015_CR24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309\u2013322 (2012).","journal-title":"Cancer Cell"},{"key":"BFncb3015_CR25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/cam.20875","volume":"6","author":"BG Cuiffo","year":"2012","unstructured":"Cuiffo, B. G. & Karnoub, A. E. Mesenchymal stem cells in tumor development: emerging roles and concepts. Cell Adh. Migr. 6, 220\u2013230 (2012).","journal-title":"Cell Adh. Migr."},{"key":"BFncb3015_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2014.05.009","volume":"19","author":"Y Shaked","year":"2014","unstructured":"Shaked, Y., McAllister, S., Fainaru, O. & Almog, N. Tumor dormancy and the angiogenic switch: possible implications of bone marrow-derived cells. Curr. Pharm. Des. 19, 1\u201314 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"BFncb3015_CR27","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1172\/JCI41649","volume":"120","author":"KJ Eash","year":"2010","unstructured":"Eash, K. J., Greenbaum, A. M., Gopalan, P. K. & Link, D. C. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Invest. 120, 2423\u20132431 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFncb3015_CR28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(03)00263-2","volume":"19","author":"C Martin","year":"2003","unstructured":"Martin, C. et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19, 583\u2013593 (2003).","journal-title":"Immunity"},{"key":"BFncb3015_CR29","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1126\/science.1064081","volume":"294","author":"DE Wright","year":"2001","unstructured":"Wright, D. E., Wagers, A. J., Gulati, A. P., Johnson, F. L. & Weissman, I. L. Physiological migration of hematopoietic stem and progenitor cells. Science 294, 1933\u20131936 (2001).","journal-title":"Science"},{"key":"BFncb3015_CR30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev.immunol.21.120601.141007","volume":"21","author":"M Kondo","year":"2003","unstructured":"Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21, 759\u2013806 (2003).","journal-title":"Annu. Rev. Immunol."},{"key":"BFncb3015_CR31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1084\/jem.20101700","volume":"208","author":"MJ Christopher","year":"2011","unstructured":"Christopher, M. J., Rao, M., Liu, F., Woloszynek, J. R. & Link, D. C. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J. Exp. Med. 208, 251\u2013260 (2011).","journal-title":"J. Exp. Med."},{"key":"BFncb3015_CR32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1084\/jem.20101688","volume":"208","author":"A Chow","year":"2011","unstructured":"Chow, A. et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 208, 261\u2013271 (2011).","journal-title":"J. Exp. Med."},{"key":"BFncb3015_CR33","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1182\/blood-2009-11-253534","volume":"116","author":"IG Winkler","year":"2010","unstructured":"Winkler, I. G. et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116, 4815\u20134828 (2010).","journal-title":"Blood"},{"key":"BFncb3015_CR34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nbt1323","volume":"25","author":"F Shojaei","year":"2007","unstructured":"Shojaei, F. et al. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat. Biotechnol. 25, 911\u2013920 (2007).","journal-title":"Nat. Biotechnol."},{"key":"BFncb3015_CR35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nature06348","volume":"450","author":"F Shojaei","year":"2007","unstructured":"Shojaei, F. et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450, 825\u2013831 (2007).","journal-title":"Nature"},{"key":"BFncb3015_CR36","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2008.04.045","volume":"133","author":"SS McAllister","year":"2008","unstructured":"McAllister, S. S. et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133, 994\u20131005 (2008).","journal-title":"Cell"},{"key":"BFncb3015_CR37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1172\/JCI43757","volume":"121","author":"M Elkabets","year":"2011","unstructured":"Elkabets, M. et al. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J. Clin. Invest. 121, 784\u2013799 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFncb3015_CR38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.moh.0000219664.26528.da","volume":"13","author":"HG Kopp","year":"2006","unstructured":"Kopp, H. G., Ramos, C. A. & Rafii, S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr. Opin. Hematol. 13, 175\u2013181 (2006).","journal-title":"Curr. Opin. Hematol."},{"key":"BFncb3015_CR39","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1073\/pnas.0710516105","volume":"105","author":"S Purhonen","year":"2008","unstructured":"Purhonen, S. et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl Acad. Sci. USA 105, 6620\u20136625 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncb3015_CR40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 121, 335\u2013348 (2005).","journal-title":"Cell"},{"key":"BFncb3015_CR41","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V97.11.3354","volume":"97","author":"K Hattori","year":"2001","unstructured":"Hattori, K. et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97, 3354\u20133360 (2001).","journal-title":"Blood"},{"key":"BFncb3015_CR42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","volume":"1","author":"DG DeNardo","year":"2011","unstructured":"DeNardo, D. G. et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 1, 54\u201367 (2011).","journal-title":"Cancer Discov."},{"key":"BFncb3015_CR43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.molmed.2013.12.002","volume":"20","author":"HJ Anders","year":"2014","unstructured":"Anders, H. J., Romagnani, P. & Mantovani, A. Pathomechanisms: homeostatic chemokines in health, tissue regeneration, and progressive diseases. Trends Mol. Med. 20, 154\u2013165 (2014).","journal-title":"Trends Mol. Med."},{"key":"BFncb3015_CR44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557\u2013563 (2007).","journal-title":"Nature"},{"key":"BFncb3015_CR45","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/stem.187","volume":"27","author":"S Kidd","year":"2009","unstructured":"Kidd, S. et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27, 2614\u20132623 (2009).","journal-title":"Stem Cells"},{"key":"BFncb3015_CR46","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood-2003-01-0190","volume":"102","author":"C Melani","year":"2003","unstructured":"Melani, C., Chiodoni, C., Forni, G. & Colombo, M. P. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB\/c mice suppresses immune reactivity. Blood 102, 2138\u20132145 (2003).","journal-title":"Blood"},{"key":"BFncb3015_CR47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","volume":"16","author":"P Serafini","year":"2006","unstructured":"Serafini, P., Borrello, I. & Bronte, V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16, 53\u201365 (2006).","journal-title":"Semin. Cancer Biol."},{"key":"BFncb3015_CR48","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","volume":"166","author":"B Almand","year":"2001","unstructured":"Almand, B. et al. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678\u2013689 (2001).","journal-title":"J. Immunol."},{"key":"BFncb3015_CR49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0192-0561(99)00044-2","volume":"21","author":"MR Young","year":"1999","unstructured":"Young, M. R., Wright, M. A., Vellody, K. & Lathers, D. M. Skewed differentiation of bone marrow CD34+ cells of tumor bearers from dendritic toward monocytic cells, and the redirection of differentiation toward dendritic cells by 1alpha, 25-dihydroxyvitamin D3. Int. J. Immunopharmacol. 21, 675\u2013688 (1999).","journal-title":"Int. J. Immunopharmacol."},{"key":"BFncb3015_CR50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccr.2007.12.004","volume":"13","author":"L Yang","year":"2008","unstructured":"Yang, L. et al. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13, 23\u201335 (2008).","journal-title":"Cancer Cell"},{"key":"BFncb3015_CR51","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski, F. K. et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612\u2013616 (2009).","journal-title":"Science"},{"key":"BFncb3015_CR52","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1073\/pnas.1113744109","volume":"109","author":"V Cortez-Retamozo","year":"2012","unstructured":"Cortez-Retamozo, V. et al. Origins of tumor-associated macrophages and neutrophils. Proc. Natl Acad. Sci. USA 109, 2491\u20132496 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncb3015_CR53","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2012.10.015","volume":"38","author":"V Cortez-Retamozo","year":"2013","unstructured":"Cortez-Retamozo, V. et al. Angiotensin II drives the production of tumor-promoting macrophages. Immunity 38, 296\u2013308 (2013).","journal-title":"Immunity"},{"key":"BFncb3015_CR54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1200\/JCO.2001.19.2.577","volume":"19","author":"S Ugurel","year":"2001","unstructured":"Ugurel, S., Rappl, G., Tilgen, W. & Reinhold, U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J. Clin. Oncol. 19, 577\u2013583 (2001).","journal-title":"J. Clin. Oncol."},{"key":"BFncb3015_CR55","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mpo.1136","volume":"36","author":"G Holzer","year":"2001","unstructured":"Holzer, G. et al. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors. Med. Pediatr. Oncol. 36, 601\u2013604 (2001).","journal-title":"Med. Pediatr. Oncol."},{"key":"BFncb3015_CR56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00000658-200102000-00012","volume":"233","author":"RT Poon","year":"2001","unstructured":"Poon, R. T. et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann. Surg. 233, 227\u2013235 (2001).","journal-title":"Ann. Surg."},{"key":"BFncb3015_CR57","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ Van de Vijver","year":"2002","unstructured":"Van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999\u20132009 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFncb3015_CR58","first-page":"3417","volume":"62","author":"PS Rudland","year":"2002","unstructured":"Rudland, P. S. et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res. 62, 3417\u20133427 (2002).","journal-title":"Cancer Res."},{"key":"BFncb3015_CR59","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1073\/pnas.0502178102","volume":"102","author":"G Mor","year":"2005","unstructured":"Mor, G. et al. Serum protein markers for early detection of ovarian cancer. Proc. Natl Acad. Sci. USA 102, 7677\u20137682 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncb3015_CR60","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/jcb.21520","volume":"102","author":"AB Tuck","year":"2007","unstructured":"Tuck, A. B., Chambers, A. F. & Allan, A. L. Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. J. Cell. Biochem. 102, 859\u2013868 (2007).","journal-title":"J. Cell. Biochem."},{"key":"BFncb3015_CR61","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10555-013-9441-9","volume":"32","author":"AS Azmi","year":"2013","unstructured":"Azmi, A. S., Bao, B. & Sarkar, F. H. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 32, 623\u2013642 (2013).","journal-title":"Cancer Metastasis Rev."},{"key":"BFncb3015_CR62","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1078-0432.CCR-12-0962","volume":"19","author":"F Pucci","year":"2013","unstructured":"Pucci, F. & Pittet, M. J. Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivo. Clin. Cancer Res. 19, 2598\u20132604 (2013).","journal-title":"Clin. Cancer Res."},{"key":"BFncb3015_CR63","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883\u2013891 (2012).","journal-title":"Nat. Med."},{"key":"BFncb3015_CR64","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1158\/0008-5472.CAN-11-0241","volume":"71","author":"C Grange","year":"2011","unstructured":"Grange, C. et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 71, 5346\u20135356 (2011).","journal-title":"Cancer Res."},{"key":"BFncb3015_CR65","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/ijc.28678","volume":"135","author":"E Fremder","year":"2014","unstructured":"Fremder, E. et al. Tumor-derived microparticles induce bone marrow-derived cell mobilization and tumor homing: A process regulated by osteopontin. Int. J. Cancer 135, 270\u2013281 (2014).","journal-title":"Int. J. Cancer"},{"key":"BFncb3015_CR66","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.med.49.1.407","volume":"49","author":"BR Zetter","year":"1998","unstructured":"Zetter, B. R. Angiogenesis and tumor metastasis. Annu. Rev. Med. 49, 407\u2013424 (1998).","journal-title":"Annu. Rev. Med."},{"key":"BFncb3015_CR67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563\u2013572 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR68","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler, I. J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453\u2013458 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR69","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta, G. P. & Massague, J. Cancer metastasis: building a framework. Cell 127, 679\u2013695 (2006).","journal-title":"Cell"},{"key":"BFncb3015_CR70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1535-6108(02)00153-8","volume":"2","author":"S Hiratsuka","year":"2002","unstructured":"Hiratsuka, S. et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2, 289\u2013300 (2002).","journal-title":"Cancer Cell"},{"key":"BFncb3015_CR71","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/ncb1507","volume":"8","author":"S Hiratsuka","year":"2006","unstructured":"Hiratsuka, S., Watanabe, A., Aburatani, H. & Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369\u20131375 (2006).","journal-title":"Nat. Cell Biol."},{"key":"BFncb3015_CR72","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820\u2013827 (2005).","journal-title":"Nature"},{"key":"BFncb3015_CR73","doi-asserted-by":"crossref","first-page":"e6525","DOI":"10.1371\/journal.pone.0006525","volume":"4","author":"MR Dawson","year":"2009","unstructured":"Dawson, M. R., Duda, D. G., Chae, S. S., Fukumura, D. & Jain, R. K. VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation. PLoS ONE 4, e6525 (2009).","journal-title":"PLoS ONE"},{"key":"BFncb3015_CR74","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2011.01.002","volume":"21","author":"H Peinado","year":"2011","unstructured":"Peinado, H., Lavotshkin, S. & Lyden, D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol. 21, 139\u2013146 (2011).","journal-title":"Semin. Cancer Biol."},{"key":"BFncb3015_CR75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","volume":"15","author":"JT Erler","year":"2009","unstructured":"Erler, J. T. et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35\u201344 (2009).","journal-title":"Cancer Cell"},{"key":"BFncb3015_CR76","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/0008-5472.CAN-11-3873","volume":"72","author":"J Sceneay","year":"2012","unstructured":"Sceneay, J. et al. Primary tumor hypoxia recruits CD11b+\/Ly6Cmed\/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 72, 3906\u20133911 (2012).","journal-title":"Cancer Res."},{"key":"BFncb3015_CR77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature07623","volume":"457","author":"S Kim","year":"2009","unstructured":"Kim, S. et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102\u2013106 (2009).","journal-title":"Nature"},{"key":"BFncb3015_CR78","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10555-013-9420-1","volume":"32","author":"J Sceneay","year":"2013","unstructured":"Sceneay, J., Smyth, M. J. & Moller, A. The pre-metastatic niche: finding common ground. Cancer Metastasis Rev. 32, 449\u2013464 (2013).","journal-title":"Cancer Metastasis Rev."},{"key":"BFncb3015_CR79","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI29919","volume":"117","author":"CL Tsou","year":"2007","unstructured":"Tsou, C. L. et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902\u2013909 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFncb3015_CR80","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1073\/pnas.0903120106","volume":"106","author":"SY Kang","year":"2009","unstructured":"Kang, S. Y. et al. Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1. Proc. Natl Acad. Sci. USA 106, 12115\u201312120 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncb3015_CR81","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10585-011-9410-z","volume":"28","author":"F Schelter","year":"2011","unstructured":"Schelter, F. et al. Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10. Clin. Exp. Metastasis 28, 793\u2013802 (2011).","journal-title":"Clin. Exp. Metastasis"},{"key":"BFncb3015_CR82","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1593\/neo.09822","volume":"11","author":"T Jung","year":"2009","unstructured":"Jung, T. et al. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 11, 1093\u20131105 (2009).","journal-title":"Neoplasia"},{"key":"BFncb3015_CR83","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1158\/0008-5472.CAN-08-1673","volume":"68","author":"AG Taranova","year":"2008","unstructured":"Taranova, A. G. et al. Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung. Cancer Res. 68, 8582\u20138589 (2008).","journal-title":"Cancer Res."},{"key":"BFncb3015_CR84","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pharmthera.2013.10.006","volume":"141","author":"M Esposito","year":"2014","unstructured":"Esposito, M. & Kang, Y. Targeting tumor-stromal interactions in bone metastasis. Pharmacol. Ther. 141, 222\u2013233 (2014).","journal-title":"Pharmacol. Ther."},{"key":"BFncb3015_CR85","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc2375","volume":"8","author":"K Pantel","year":"2008","unstructured":"Pantel, K., Brakenhoff, R. H. & Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8, 329\u2013340 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR86","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","volume":"9","author":"CA Klein","year":"2009","unstructured":"Klein, C. A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9, 302\u2013312 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR87","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2407-11-365","volume":"11","author":"LD Roy","year":"2011","unstructured":"Roy, L. D. et al. Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer. BMC Cancer 11, 365 (2011).","journal-title":"BMC Cancer"},{"key":"BFncb3015_CR88","first-page":"2162","volume":"62","author":"GN Naumov","year":"2002","unstructured":"Naumov, G. N. et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res. 62, 2162\u20132168 (2002).","journal-title":"Cancer Res."},{"key":"BFncb3015_CR89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2010.03.004","volume":"294","author":"N Almog","year":"2010","unstructured":"Almog, N. Molecular mechanisms underlying tumor dormancy. Cancer Lett. 294, 139\u2013146 (2010).","journal-title":"Cancer Lett."},{"key":"BFncb3015_CR90","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1084\/jem.162.5.1665","volume":"162","author":"CA Mullen","year":"1985","unstructured":"Mullen, C. A., Urban, J. L., Van Waes, C., Rowley, D. A. & Schreiber, H. Multiple cancers. Tumor burden permits the outgrowth of other cancers. J. Exp. Med. 162, 1665\u20131682 (1985).","journal-title":"J. Exp. Med."},{"key":"BFncb3015_CR91","first-page":"3569","volume":"60","author":"RT Reilly","year":"2000","unstructured":"Reilly, R. T. et al. HER-2\/neu is a tumor rejection target in tolerized HER-2\/neu transgenic mice. Cancer Res. 60, 3569\u20133576 (2000).","journal-title":"Cancer Res."},{"key":"BFncb3015_CR92","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1158\/0008-5472.CAN-10-0706","volume":"70","author":"HH Yan","year":"2010","unstructured":"Yan, H. H. et al. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Res. 70, 6139\u20136149 (2010).","journal-title":"Cancer Res."},{"key":"BFncb3015_CR93","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ccr.2011.08.012","volume":"20","author":"Z Granot","year":"2011","unstructured":"Granot, Z. et al. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 20, 300\u2013314 (2011).","journal-title":"Cancer Cell"},{"key":"BFncb3015_CR94","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1158\/0008-5472.CAN-11-2905","volume":"72","author":"D Gao","year":"2012","unstructured":"Gao, D. et al. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res. 72, 1384\u20131394 (2012).","journal-title":"Cancer Res."},{"key":"BFncb3015_CR95","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1387\/ijdb.113366zc","volume":"55","author":"Z Castano","year":"2011","unstructured":"Castano, Z., Tracy, K. & McAllister, S. S. The tumor macroenvironment and systemic regulation of breast cancer progression. Int. J. Dev. Biol. 55, 889\u2013897 (2011).","journal-title":"Int. J. Dev. Biol."},{"key":"BFncb3015_CR96","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1158\/2159-8290.CD-12-0216","volume":"2","author":"HS Kuznetsov","year":"2012","unstructured":"Kuznetsov, H. S. et al. Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. Cancer Discov. 2, 1150\u20131165 (2012).","journal-title":"Cancer Discov."},{"key":"BFncb3015_CR97","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood-2011-02-334524","volume":"118","author":"EM Battinelli","year":"2011","unstructured":"Battinelli, E. M., Markens, B. A. & Italiano, J. E. Jr Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood 118, 1359\u20131369 (2011).","journal-title":"Blood"},{"key":"BFncb3015_CR98","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1182\/blood-2011-03-344408","volume":"118","author":"RJ Nilsson","year":"2011","unstructured":"Nilsson, R. J. et al. Blood platelets contain tumor-derived RNA biomarkers. Blood 118, 3680\u20133683 (2011).","journal-title":"Blood"},{"key":"BFncb3015_CR99","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay, L. J. & Felding-Habermann, B. Contribution of platelets to tumour metastasis. Nat. Rev. Cancer 11, 123\u2013134 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR100","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","volume":"111","author":"JE Italiano Jr","year":"2008","unstructured":"Italiano, J. E. Jr et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111, 1227\u20131233 (2008).","journal-title":"Blood"},{"key":"BFncb3015_CR101","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/2159-8290.CD-12-0329","volume":"2","author":"M Labelle","year":"2012","unstructured":"Labelle, M. & Hynes, R. O. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2, 1091\u20131099 (2012).","journal-title":"Cancer Discov."},{"key":"BFncb3015_CR102","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/427787a","volume":"427","author":"J Folkman","year":"2004","unstructured":"Folkman, J. & Kalluri, R. Cancer without disease. Nature 427, 787 (2004).","journal-title":"Nature"},{"key":"BFncb3015_CR103","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/bies.200900086","volume":"31","author":"A Bateman","year":"2009","unstructured":"Bateman, A. & Bennett, H. P. The granulin gene family: from cancer to dementia. Bioessays 31, 1245\u20131254 (2009).","journal-title":"Bioessays"},{"key":"BFncb3015_CR104","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1158\/2159-8290.CD-13-0041","volume":"3","author":"Z Castano","year":"2013","unstructured":"Castano, Z. et al. Stromal EGF and IGF1 together modulate plasticity of disseminated triple negative breast tumors. Cancer Discov. 3, 922\u2013935 (2013).","journal-title":"Cancer Discov."},{"key":"BFncb3015_CR105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez, N., Truitt, M., Olson, P. & Hanahan, D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-\u03baB-dependent manner. Cancer Cell 17, 135\u2013147 (2010).","journal-title":"Cancer Cell"},{"key":"BFncb3015_CR106","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/0008-5472.CAN-13-2259","volume":"74","author":"F Bruzzese","year":"2014","unstructured":"Bruzzese, F. et al. Local and systemic pro-tumorigenic effects of fibroblast-derived GDF15\/MIC-1. Cancer Res. 74, 3408\u20133417 (2014).","journal-title":"Cancer Res."},{"key":"BFncb3015_CR107","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/08977194.2011.607137","volume":"29","author":"SN Breit","year":"2011","unstructured":"Breit, S. N. et al. The TGF-beta superfamily cytokine, MIC-1\/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth Factors 29, 187\u2013195 (2011).","journal-title":"Growth Factors"},{"key":"BFncb3015_CR108","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1158\/1078-0432.CCR-13-2735","volume":"20","author":"B Li","year":"2014","unstructured":"Li, B. et al. Id1-induced IGF-II and its autocrine\/endocrine promotion of esophageal cancer progression and chemoresistance-implications for IGF-II and IGF-IR-targeted therapy. Clin. Cancer Res. 20, 2651\u20132662 (2014).","journal-title":"Clin. Cancer Res."},{"key":"BFncb3015_CR109","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","volume":"14","author":"BE Lippitz","year":"2013","unstructured":"Lippitz, B. E. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 14, e218\u2013228 (2013).","journal-title":"Lancet Oncol."},{"key":"BFncb3015_CR110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/WCO.0b013e328364c020","volume":"26","author":"F Graus","year":"2013","unstructured":"Graus, F. & Dalmau, J. Paraneoplastic neuropathies. Curr. Opin. Neurol. 26, 489\u2013495 (2013).","journal-title":"Curr. Opin. Neurol."},{"key":"BFncb3015_CR111","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1055\/s-0037-1613413","volume":"89","author":"S Taucher","year":"2003","unstructured":"Taucher, S. et al. Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb. Haemost. 89, 1098\u20131106 (2003).","journal-title":"Thromb. Haemost."},{"key":"BFncb3015_CR112","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone, R. L. et al. Paraneoplastic thrombocytosis in ovarian cancer. N. Engl. J. Med. 366, 610\u2013618 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFncb3015_CR113","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579\u2013591 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncb3015_CR114","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ijc.11487","volume":"107","author":"R Baserga","year":"2003","unstructured":"Baserga, R., Peruzzi, F. & Reiss, K. The IGF-1 receptor in cancer biology. Int. J. Cancer 107, 873\u2013877 (2003).","journal-title":"Int. J. Cancer"},{"key":"BFncb3015_CR115","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1158\/0008-5472.CAN-06-3895","volume":"67","author":"PB Gupta","year":"2007","unstructured":"Gupta, P. B. et al. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res. 67, 2062\u20132071 (2007).","journal-title":"Cancer Res."},{"key":"BFncb3015_CR116","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/bcr2152","volume":"10","author":"R Demicheli","year":"2008","unstructured":"Demicheli, R., Biganzoli, E., Boracchi, P., Greco, M. & Retsky, M. W. Recurrence dynamics does not depend on the recurrence site. Breast Cancer Res. 10, R83 (2008).","journal-title":"Breast Cancer Res."},{"key":"BFncb3015_CR117","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1600-0463.2008.00990.x","volume":"116","author":"MW Retsky","year":"2008","unstructured":"Retsky, M. W., Demicheli, R., Hrushesky, W. J., Baum, M. & Gukas, I. D. Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS 116, 730\u2013741 (2008).","journal-title":"APMIS"},{"key":"BFncb3015_CR118","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2141.2010.08313.x","volume":"150","author":"MA Gertz","year":"2010","unstructured":"Gertz, M. A. Current status of stem cell mobilization. Br. J. Haematol. 150, 647\u2013662 (2010).","journal-title":"Br. J. Haematol."},{"key":"BFncb3015_CR119","doi-asserted-by":"crossref","first-page":"17069","DOI":"10.1073\/pnas.0708148104","volume":"104","author":"JM Ebos","year":"2007","unstructured":"Ebos, J. M., Lee, C. R., Christensen, J. G., Mutsaers, A. J. & Kerbel, R. S. Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy. Proc. Natl Acad. Sci. USA 104, 17069\u201317074 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncb3015_CR120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh334","volume":"18","author":"T Okazaki","year":"2006","unstructured":"Okazaki, T. et al. Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models. Int. Immunol. 18, 1\u20139 (2006).","journal-title":"Int. Immunol."},{"key":"BFncb3015_CR121","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1126\/science.1127592","volume":"313","author":"Y Shaked","year":"2006","unstructured":"Shaked, Y. et al. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313, 1785\u20131787 (2006).","journal-title":"Science"},{"key":"BFncb3015_CR122","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccr.2008.08.001","volume":"14","author":"Y Shaked","year":"2008","unstructured":"Shaked, Y. et al. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 14, 263\u2013273 (2008).","journal-title":"Cancer Cell"},{"key":"BFncb3015_CR123","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1078-0432.CCR-12-2241","volume":"19","author":"MH Barcellos-Hoff","year":"2013","unstructured":"Barcellos-Hoff, M. H. Does microenvironment contribute to the etiology of estrogen receptor-negative breast cancer? Clin. Cancer Res. 19, 541\u2013548 (2013).","journal-title":"Clin. Cancer Res."},{"key":"BFncb3015_CR124","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/1078-0432.CCR-09-0095","volume":"15","author":"JM Ebos","year":"2009","unstructured":"Ebos, J. M., Lee, C. R. & Kerbel, R. S. Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy. Clin. Cancer Res. 15, 5020\u20135025 (2009).","journal-title":"Clin. Cancer Res."},{"key":"BFncb3015_CR125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJ Guthrie","year":"2013","unstructured":"Guthrie, G. J. et al. The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Crit. Rev. Oncol. Hematol. 88, 218\u2013230 (2013).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"BFncb3015_CR126","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/bjc.2013.346","volume":"109","author":"G Absenger","year":"2013","unstructured":"Absenger, G. et al. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br. J. Cancer 109, 395\u2013400 (2013).","journal-title":"Br. J. Cancer"},{"key":"BFncb3015_CR127","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/bjc.2013.332","volume":"109","author":"M Stotz","year":"2013","unstructured":"Stotz, M. et al. Increased neutrophil\u2013lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br. J. Cancer 109, 416\u2013421 (2013).","journal-title":"Br. J. Cancer"},{"key":"BFncb3015_CR128","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/bjc.2013.350","volume":"109","author":"M Ishizuka","year":"2013","unstructured":"Ishizuka, M., Nagata, H., Takagi, K., Iwasaki, Y. & Kubota, K. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br. J. Cancer 109, 401\u2013407 (2013).","journal-title":"Br. J. Cancer"},{"key":"BFncb3015_CR129","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","volume":"39","author":"DC McMillan","year":"2012","unstructured":"McMillan, D. C. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat. Rev. 39, 534\u2013540 (2012).","journal-title":"Cancer Treat. Rev."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncb3015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncb3015","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncb3015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:44:15Z","timestamp":1684439055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncb3015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":129,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFncb3015"],"URL":"https:\/\/doi.org\/10.1038\/ncb3015","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"1 August 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}